‘3D drugs promise early cure with no side effects’

The tech can also create implantable delivery devices, says expert

November 28, 2018 12:54 am | Updated 12:54 am IST - ONGOLE

Frontier research: Dr.G.Himabindu being felicitated by RIMS Director Sk. Mastan Saheb and Pharmacology Department head Solomon Raj, in Ongole on Tuesday.

Frontier research: Dr.G.Himabindu being felicitated by RIMS Director Sk. Mastan Saheb and Pharmacology Department head Solomon Raj, in Ongole on Tuesday.

A patient may soon get customised drugs for an early cure without side effects thanks to 3D-printing technology, according to Dr.G.Himabindu of the Rajiv Gandhi Institute of Medical Sciences here.

Returning from Rome, where she delivered a keynote address at an international conference on ‘Euro Global Congress on Pharma and Clinical trials’ from November 14 to 16, she told the media here on Tuesday that the new technology makes drug delivery safe and more potent.

A pharmacist could print and dispense personalised medication through an automated 3D printing system and the dosage can be adjusted based on clinical response, said Dr. Himabindu, Assistant Professor in Pharmacology at RIMS. Implantable drug delivery devices with novel drug release profiles could also be created using 3D printing, she explained. A person suffering from pancreatic cancer could be effectively treated by using the technology without side effects, she added.

‘Polypill a boon’

Dr.Himbabindu, who has specialised in geriatrics, said polypill would be a boon for the elderly suffering from hypertension and type-2 diabetes. A high drug load could be delivered in a single dose using ZipDose Technology, she said, adding 3D printed drug, Spritam, was now available to treat epilepsy.

Dr.Himabindu, who also presented a paper on minimising adverse drug reactions in older adults, was felicitated by a RIMS team of doctors led by its Director Sk. Mastan Saheb.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.